JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1 Item
JAK2 inhibitor
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells.